Cytokine profile and markers of fat metabolism in bronchial asthma patients with obesity and multimorbidity

Abstract

BACKGROUND: The number of people with multimorbidity has been steadily increasing in recent years. In patients with bronchial asthma, the level of control and cytokine profile with markers of fat metabolism may depend on body mass index and the presence of multimorbidity.

AIM: To assess the relationships of disease control level, cytokine profile, adiponectins and oxidant stress level in asthma patients depending on body mass index and multimorbidity

MATERIALS AND METHODS: Patients with asthma (n = 237) were divided into 3 groups depending on body mass index. We analyzed multimorbid pathology, assessed asthma control according to Asthma Control Questionnaire-5; determined interleukin-6, -4, resistin, tumor necrosis factor-alpha, degree of oxidative damage to biomolecules, antioxidant capacity of serum, leptin, adiponectin levels. Statistical analysis: Microsoft Excel, Statistica 12.0, Statgraphics XVIII.

RESULTS: There were significantly more (p < 0.05) comorbidities among the obese and asthma patients. The levels of leptin, resistin, interleukin-6, tumor necrosis factor-alpha, and degree of oxidative damage to biomolecules were significantly higher in the obese group. Direct correlations were found between body mass index, cumulative pathology rating scale, Asthma Control Questionnaire-5 and interleukin-6, tumor necrosis factor-alpha, degree of oxidative damage to biomolecules, leptin, and resistin control levels of asthma. An inverse correlation with adiponectin was detected with body mass index.

CONCLUSIONS: Authentic increase of adipokins and anti-inflammatory cytokines, oxidative stress indexes and decrease of anti-inflammatory effects of adiponectin are noted in patients with asthma and obese patients. Multimorbidity further contributes to the development of systemic inflammation in patients with asthma. Obesity and multimorbidity are factors complicating the achievement of asthma control.

Keywords

asthma / obesity / multimorbidity / asthma control / cytokine / adipokin / interleukin

References

[1] Global Strategy for Asthma Management and Prevention (2022 update). [Internet]. Available from: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf

[2] Global Strategy for Asthma Management and Prevention (2022 update) [Электронный ресурс]. Режим доступа: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf

[3] Wang G, McDonald VM, Gibson PG. Management of severe asthma: from stepwise approach to therapy to treatable traits? Precis Clin Med. 2021;4(4):293–296. DOI: 10.1093/pcmedi/pbab028

[4] Wang G., McDonald V.M., Gibson P.G. Management of severe asthma: from stepwise approach to therapy to treatable traits? // Precis. Clin. Med. 2021. Vol. 4, No. 4. P. 293–296. DOI: 10.1093/pcmedi/pbab028

[5] Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5–66. (In Russ.) DOI: 10.15829/1728-8800-2019-1-5-66

[6] Оганов Р.Г., Симаненков В.И., Бакулин И.Г. и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения // Кардиоваскулярная терапия и профилактика. 2019. Т. 18, № 1. С. 5–66. DOI: 10.15829/1728-8800-2019-1-5-66

[7] Tribuntseva LV, Avdeyev SN, Budnevskiy AV, et al. Combined effect of multimorbidity and increased body mass index on control of bronchial asthma and quality of patients’ life. I.P. Pavlov Russian Medical Biological Herald. 2023;31(1):37–48. (In Russ.) DOI: 10.17816/PAVLOVJ111895

[8] Трибунцева Л.В., Авдеев С.Н., Будневский А.В. и др. Сочетанное влияние мультиморбидности и повышенного индекса массы тела на контроль бронхиальной астмы и качество жизни пациентов // Российский медико-биологический вестник им. академика И.П. Павлова. 2023. Т. 31, № 1. C. 37–48. DOI: 10.17816/PAVLOVJ111895

[9] Ermolova AV, Budnevsky AV, Malysh EYu, et al. Bronchial asthma and metabolic syndrome. Clinical Medicine. 2015;93(6):44–49. (In Russ.)

[10] Ермолова А.В., Будневский А.В., Малыш Е.Ю. и др. Клинико-функциональные особенности бронхиальной астмы у больных с метаболическим синдромом // Клиническая медицина. 2015. Т. 93, № 6. С. 44–49.

[11] Markova TN, Fomina DS, Kostenko AA, Bobrikova EN. Obesity and bronchial asthma: two diseases with common aspects of pathogenesis. Profilakticheskaya Meditsina. 2020;23(4):126–132. (In Russ.) DOI: 10.17116/profmed202023041126

[12] Маркова Т.Н., Фомина Д.С., Костенко А.А., Бобрикова Е.Н. Ожирение и бронхиальная астма: два заболевания с общими аспектами патогенеза // Профилактическая медицина. 2020. Т. 23, № 4. С. 126–132. DOI: 10.17116/profmed202023041126

[13] Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6concentrations, metabolic dysfunction, and asthma severity: a cross-sectional cohorts. Lancet Respir Med. 2016;4:574–584. DOI: 10.1016/S2213-2600(16)30048-0

[14] Peters M.C., McGrath K.W., Hawkins G.A. et al. Plasma interleukin-6concentrations, metabolic dysfunction, and asthma severity: a cross-sectional cohorts // Lancet Respir. Med. 2016. Vol. 4. P. 574–584. DOI: 10.1016/S2213-2600(16)30048-0

[15] Carbone F, La Rocca C, Matarese G. Immunological functions of leptin and adiponectin. Biochimie. 2012;94(10):2082–2088. DOI: 10.1016/j.biochi.2012.05.018

[16] Carbone F., La Rocca C., Matarese G. Immunological functions of leptin and adiponectin // Biochimie. 2012. Vol. 94, No. 10. P. 2082–2088. DOI: 10.1016/j.biochi.2012.05.018

[17] Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300(2):472–476. DOI: 10.1016/s0006-291x(02)02841-3

[18] Patel L., Buckels A.C., Kinghorn I.J. et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators // Biochem. Biophys. Res. Commun. 2003. Vol. 300, No. 2. P. 472–476. DOI: 10.1016/s0006-291x(02)02841-3

[19] Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol. 2006;3(1):29–34.

[20] Pang S.S., Le Y.Y. Role of resistin in inflammation and inflammation-related diseases // Cell. Mol. Immunol. 2006. Vol. 3, No. 1. P. 29–34.

[21] Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007;9(3):282–289. DOI: 10.1111/j.1463-1326.2006.00610.x

[22] Oh D.K., Ciaraldi T., Henry R.R. Adiponectin in health and disease // Diabetes Obes. Metab. 2007. Vol. 9, No. 3. P. 282–289. DOI: 10.1111/j.1463-1326.2006.00610.x

[23] Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 2006;55(6):1840–1846. DOI: 10.2337/db05-1174

[24] Ouedraogo R., Wu X., Xu S.Q. et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway // Diabetes. 2006. Vol. 55, No. 6. P. 1840–1846. DOI: 10.2337/db05-1174

[25] Dedov II, Mokrysheva NG, Mel’nichenko GA, et al. Obesity. Clinical guidelines. Consilium Medicum. 2021;23(4):311–325. (In Russ.). DOI: 10.26442/20751753.2021.4.200832

[26] Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А. и др. Ожирение. Клинические рекомендации // Consilium Medicum. 2021. Т. 23, № 4. С. 311–325. DOI: 10.26442/20751753.2021.4.200832

[27] Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. DOI: 10.1034/j.1399-3003.1999.14d29.x

[28] Juniper E.F., O’Byrne P.M., Guyatt G.H. et al. Development and validation of a questionnaire to measure asthma control // Eur. Respir. J. 1999. Vol. 14, No. 4. P. 902–907. DOI: 10.1034/j.1399-3003.1999.14d29.x

[29] Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;(16)5:622–626. DOI: 10.1111/j.1532-5415.1968.tb02103.x

[30] Linn B.S., Linn M.W., Gurel L. Cumulative illness rating scale // J. Am. Geriatr. Soc. 1968. Vol. 16, No. 5. P. 622–626. DOI: 10.1111/j.1532-5415.1968.tb02103.x

[31] Obesity and Overweight Factsheet [Internet]. WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed: 23.08.2023.

[32] Obesity and Overweight Factsheet [Электронный ресурс] // WHO. Режим доступа: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Дата обращения: 23.08.2023.

[33] Dixon AE, Que LG. Obesity and asthma. Semin Respir Crit Care Med. 2022;43(5):662–674. DOI: 10.1055/s-0042-1742384

[34] Dixon A.E., Que L.G. Obesity and Asthma // Semin. Respir. Crit. Care Med. 2022. Vol. 43, No. 5. P. 662–674. DOI: 10.1055/s-0042-1742384

[35] Kytikova OY, Antonyuk MV, Gvozdenko TA, Novgorodtseva TР. Metabolic aspects of the relationship of asthma and obesity. Obesity and metabolism. 2018;15(4):9–14. (In Russ.). DOI: 10.14341/omet9578

[36] Кытикова О.Ю., Антонюк М.В., Гвозденко Т.А., Новгородцева Т.П. Метаболические аспекты взаимосвязи ожирения и бронхиальной астмы // Ожирение и метаболизм. 2018. Т. 15, № 4. С. 9–14. DOI: 10.14341/omet9578

[37] Wonisch W, Falk A, Sundl I, et al. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male. 2012;15(3):159–165. DOI: 10.3109/13685538.2012.669436

[38] Wonisch W., Falk A., Sundl I. et al. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males // Aging Male. 2012. Vol. 15, No. 3. P. 159–165. DOI: 10.3109/13685538.2012.669436

[39] Grasemann H, Holguin F. Oxidative stress and obesity-related asthma. Paediatr Respir Rev. 2021;37:18–21. DOI: 10.1016/j.prrv.2020.05.004

[40] Grasemann H., Holguin F. Oxidative stress and obesity-related asthma // Paediatr. Respir. Rev. 2021. Vol. 37. P. 18–21. DOI: 10.1016/j.prrv.2020.05.004

[41] Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50(4):975–991. DOI: 10.1016/j.immuni.2019.03.018

[42] Lambrecht B.N., Hammad H., Fahy J.V. The cytokines of asthma // Immunity. 2019. Vol. 50, No. 4. P. 975–991. DOI: 10.1016/j.immuni.2019.03.018

[43] Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, Sánchez-Margalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21(16):5887. DOI: 10.3390/ijms21165887

[44] Pérez-Pérez A., Sánchez-Jiménez F., Vilariño-García T., Sánchez-Margalet V. Role of leptin in inflammation and vice versa // Int. J. Mol. Sci. 2020. Vol. 21, No. 16. P. 5887. DOI: 10.3390/ijms21165887

[45] Sood A, Ford ES, Camargo CA. Association between leptin and asthma in adults. Thorax. 2006;61(4):300–305. DOI: 10.1136/thx.2004.031468

[46] Sood A., Ford E.S., Camargo C.A. Association between leptin and asthma in adults // Thorax. 2006. Vol. 61, No. 4. P. 300–305. DOI: 10.1136/thx.2004.031468

[47] Kytikova OY, Antonyuk MV, Gvozdenko TA, Novgorodtseva TP. The pathophysiological role of adipokines in the development of bronchial asthma combined with obesity. Terapevticheskii arkhiv. 2021. Vol. 93. N. 3. P. 327–332. (In Russ.) DOI: 10.26442/00403660.2021.03.200659

[48] Кытикова О.Ю., Антонюк М.В., Гвозденко Т.А., Новгородцева Т.П. Патофизиологическая роль адипокинов в развитии бронхиальной астмы у больных с ожирением // Терапевтический архив. 2021. Т. 93, № 3. С. 327–332. DOI: 10.26442/00403660.2021.03.200659

[49] Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–584. DOI: 10.1016/S2213-2600(16)30048-0

[50] Peters M.C., McGrath K.W., Hawkins G.A. et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts // Lancet Respir. Med. 2016. Vol. 4, No. 7. P. 574–584. DOI: 10.1016/S2213-2600(16)30048-0

[51] Topolyanskaya SV. Interleukin 6 in aging and age-related diseases. The Clinician. 2020;14(3–4):10–17. (In Russ.) DOI: 10.17650/1818-8338-2020-14-3-4-K-633

[52] Тополянская С.В. Роль интерлейкина 6 при старении и возрастассоциированных заболеваниях // Клиницист. 2020. Т. 14, № 3–4. С. 10–17. DOI: 10.17650/1818-8338-2020-14-3-4-K633

[53] Fève B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305–311. DOI: 10.1038/nrendo.2009.62

[54] Fève B., Bastard J.P. The role of interleukins in insulin resistance and type 2 diabetes mellitus // Nat. Rev. Endocrinol. 2009. Vol. 5, No. 6. P. 305–311. DOI: 10.1038/nrendo.2009.62

[55] Turan N, Edwards MJ, Bates S, et al. IL-6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function. Clin Exp Allergy. 2018;48(4):475–478. DOI: 10.1111/cea.13085

[56] Turan N., Edwards M.J., Bates S. et al. IL-6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function // Clin. Exp. Allergy. 2018. Vol. 48, No. 4. P. 475–478. DOI: 10.1111/cea.13085

[57] Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNFα in pulmonary pathophysiology. Respir Res. 2006;7(1):125. DOI: 10.1186/1465-9921-7-125

[58] Mukhopadhyay S., Hoidal J.R., Mukherjee T.K. Role of TNFα in pulmonary pathophysiology // Respir. Res. 2006. Vol. 7, No. 1. P. 125. DOI: 10.1186/1465-9921-7-125

[59] Markova TN, Mishchenko NK, Petina DV. Adipocytokines: modern definition, classification and physiological role. Problems of Endocrinology. 2022;68(1):73–80. (In Russ.). DOI: 10.14341/probl12805

[60] Маркова Т.Н., Мищенко Н.К., Петина Д.В. Адипоцитокины: современный взгляд на дефиницию, классификацию и роль в организме // Проблемы Эндокринологии. 2022. Т. 68, № 1. С. 73–80. DOI: 10.14341/probl12805

[61] Bobkova IN, Gussaova SS, Stavrovskaya EV, et al. Serum levels of resistin in patients with morbid obesity. Klinicheskaya farmakologiya i terapiya. 2019;28(4):24–29. (In Russ.) DOI: 10.32756/0869-5490-2019-4-24-29

[62] Бобкова И.Н., Гуссаова С.С., Ставровская Е.В. и др. Исследование сывороточного уровня резистина у пациентов с морбидным ожирением // Клиническая фармакология и терапия. 2019. Т. 28, № 4. С. 24–29. DOI: 10.32756/0869-5490-2019-4-24-29

[63] Osman AME, Motawie AAM, Abd Al-Aziz AM, et al. Role of adiponectin, resistin and monocyte chemo-attractant protein-1 in overweight/obese asthma phenotype in children. BMC Pediatr. 2023;23(1):226. DOI: 10.1186/s12887-023-04046-6

[64] Osman A.M.E., Motawie A.A.M., Abd Al-Aziz A.M. et al. Role of adiponectin, resistin and monocyte chemo-attractant protein-1 in overweight/obese asthma phenotype in children // BMC Pediatr. 2023. Vol. 23, No. 1. P. 226. DOI: 10.1186/s12887-023-04046-6

Funding

Правительство РФThe Government of the Russian FederationThe Government of the Russian Federation(НШ-4994.2018.7)

RIGHTS & PERMISSIONS

Eco-Vector